Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice
Recent reports provide evidence-based guidelines for the withdrawal of inhaled corticosteroids (ICS) in COPD, but data on patients treated with ICS-based triple therapy are sparse and contradictory. We assessed the effect of ICS discontinuation on the incidence of severe exacerbation and pneumonia i...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2022-12-01
|
| Schriftenreihe: | COPD |
| Schlagworte: | |
| Online-Zugang: | http://dx.doi.org/10.1080/15412555.2022.2045265 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
